Hungary Pharmaceuticals and Healthcare Report Q1 2014 - a new market research report on companiesandmarkets.com
PR-Inside.com: 2014-04-02 15:34:02
We do not envisage much improvement in terms of Hungary´s operating environment for pharmaceutical manufacturers heading into 2014. Despite the volume demand supported by population ageing and epidemiological factors, continued downward pressure on prescription prices remains a major issue.
Headline Expenditure Projections:
- Pharmaceuticals: HUF619.15bn (US$2.75bn) in 2012 to HUF574.65bn (US$2.58bn) in 2013; -7.2% in local currency terms and -6.2% in US dollar terms. Local currency forecast broadly in line with the previous quarter´s projection.
Click for report details: www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..
Browse all Healthcare and Medical Market Research Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..
Browse all Healthcare and Medical Company Profile Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..
Browse all Latest Market Research Reports www.companiesandmarkets.com/Market/All/Market-Research?aCode=f3f ..
Companiesandmarkets.com is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles, Companiesandmarkets.comâs online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.